You are here:

fosaprepitant (Ivemend)

Withdrawn

Advice has been withdrawn from the website

fosaprepitant (Ivemend®) 115mg powder for solution for infusion, for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy was reviewed by SMC in October 2008.  However from 15 February, 2011, fosaprepitant (Ivemend®) 115mg powder for solution for infusion ceased to be available in the UK and therefore the SMC advice has been removed from the website.

Drug Details

Drug Name: fosaprepitant (Ivemend)
SMC Drug ID: 506/08
Manufacturer: MSD
Indication: Prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy
BNF Category:
Sub Category: 4.6 Drugs used in nausea and vertigo
Submission Type: Full submission
Status: Withdrawn
Date Advice Published: 13 October 2008

Back